Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

doi:10.1016/j.humpath.2006.04.015

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

Human pathology - 1 Sept 2006

Kim Mi-Jung, Ro Jae Y, Ahn Sei-Hyun, Kim Hak Hee, Kim Sung-Bae, Gong Gyungyub

Abstract excerpt

DNA microarray profiling studies have led to the classification of invasive breast carcinoma into luminal/estrogen receptor-positive, normal breast-like, Her2/neu-overexpressing, and basal-like types. Among these groups, the basal-like subtype is associated with the poorest clinical outcome in We...

Topics

Adult
Aged
Aged, 80 and over
Breast Neoplasms
Breast Neoplasms, Male
ErbB Receptors
Female
Humans
Immunohistochemistry
Infant, Newborn
Keratins
Male
Middle Aged
Phenotype
Prognosis
Proto-Oncogene Proteins c-kit
Receptor, ErbB-2
Receptors, Estrogen

Source

Open in PubMed

Identifiers

PMID: 16938528
DOI: 10.1016/j.humpath.2006.04.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-16938528-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics